Low-Dose Clindamycin Achieves 82% Two-Year Success Against Prosthetic Joint Infections
A retrospective cohort study found that low-dose clindamycin, alone or with rifampicin, achieved two-year treatment success in about 82 percent ...
A retrospective cohort study found that low-dose clindamycin, alone or with rifampicin, achieved two-year treatment success in about 82 percent ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine